nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Irinotecan—pancreatic cancer	0.44	1	CbGbCtD
Penicillamine—Renal failure—Irinotecan—pancreatic cancer	0.00118	0.0021	CcSEcCtD
Penicillamine—Stomatitis—Irinotecan—pancreatic cancer	0.00117	0.00208	CcSEcCtD
Penicillamine—Alopecia—Sunitinib—pancreatic cancer	0.00115	0.00206	CcSEcCtD
Penicillamine—Renal failure—Gemcitabine—pancreatic cancer	0.00115	0.00205	CcSEcCtD
Penicillamine—Extravasation—Epirubicin—pancreatic cancer	0.00114	0.00204	CcSEcCtD
Penicillamine—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00114	0.00204	CcSEcCtD
Penicillamine—Mental disorder—Sunitinib—pancreatic cancer	0.00114	0.00204	CcSEcCtD
Penicillamine—Ageusia—Doxorubicin—pancreatic cancer	0.00114	0.00203	CcSEcCtD
Penicillamine—Stomatitis—Gemcitabine—pancreatic cancer	0.00114	0.00203	CcSEcCtD
Penicillamine—Arthralgia—Tamoxifen—pancreatic cancer	0.00113	0.00202	CcSEcCtD
Penicillamine—Anxiety—Tamoxifen—pancreatic cancer	0.00112	0.00201	CcSEcCtD
Penicillamine—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00112	0.00201	CcSEcCtD
Penicillamine—Stomatitis—Fluorouracil—pancreatic cancer	0.00112	0.002	CcSEcCtD
Penicillamine—Arthralgia—Erlotinib—pancreatic cancer	0.00112	0.00199	CcSEcCtD
Penicillamine—Anxiety—Erlotinib—pancreatic cancer	0.00111	0.00199	CcSEcCtD
Penicillamine—Dysgeusia—Sunitinib—pancreatic cancer	0.00111	0.00199	CcSEcCtD
Penicillamine—Haematuria—Gemcitabine—pancreatic cancer	0.00111	0.00199	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00111	0.00198	CcSEcCtD
Penicillamine—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.0011	0.00197	CcSEcCtD
Penicillamine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00109	0.00194	CcSEcCtD
Penicillamine—Glossitis—Epirubicin—pancreatic cancer	0.00108	0.00193	CcSEcCtD
Penicillamine—Haemoglobin—Irinotecan—pancreatic cancer	0.00108	0.00193	CcSEcCtD
Penicillamine—Haemorrhage—Irinotecan—pancreatic cancer	0.00107	0.00192	CcSEcCtD
Penicillamine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00107	0.00191	CcSEcCtD
Penicillamine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00106	0.00189	CcSEcCtD
Penicillamine—Extravasation—Doxorubicin—pancreatic cancer	0.00106	0.00189	CcSEcCtD
Penicillamine—Haemoglobin—Gemcitabine—pancreatic cancer	0.00105	0.00188	CcSEcCtD
Penicillamine—Anaemia—Sunitinib—pancreatic cancer	0.00105	0.00187	CcSEcCtD
Penicillamine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00105	0.00187	CcSEcCtD
Penicillamine—Haemorrhage—Gemcitabine—pancreatic cancer	0.00105	0.00187	CcSEcCtD
Penicillamine—Skin disorder—Erlotinib—pancreatic cancer	0.00104	0.00186	CcSEcCtD
Penicillamine—Haemoglobin—Fluorouracil—pancreatic cancer	0.00103	0.00185	CcSEcCtD
Penicillamine—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00103	0.00185	CcSEcCtD
Penicillamine—Anorexia—Tamoxifen—pancreatic cancer	0.00103	0.00184	CcSEcCtD
Penicillamine—Haemorrhage—Fluorouracil—pancreatic cancer	0.00103	0.00184	CcSEcCtD
Penicillamine—Urethral disorder—Gemcitabine—pancreatic cancer	0.00103	0.00183	CcSEcCtD
Penicillamine—Anorexia—Erlotinib—pancreatic cancer	0.00102	0.00182	CcSEcCtD
Penicillamine—Leukopenia—Sunitinib—pancreatic cancer	0.00102	0.00182	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—pancreatic cancer	0.001	0.00179	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000986	0.00176	CcSEcCtD
Penicillamine—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00098	0.00175	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000975	0.00174	CcSEcCtD
Penicillamine—Angiopathy—Irinotecan—pancreatic cancer	0.000975	0.00174	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000967	0.00173	CcSEcCtD
Penicillamine—Arthralgia—Sunitinib—pancreatic cancer	0.000967	0.00173	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00096	0.00171	CcSEcCtD
Penicillamine—Angiopathy—Gemcitabine—pancreatic cancer	0.000949	0.0017	CcSEcCtD
Penicillamine—Alopecia—Irinotecan—pancreatic cancer	0.000949	0.0017	CcSEcCtD
Penicillamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00094	0.00168	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000936	0.00167	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—pancreatic cancer	0.000936	0.00167	CcSEcCtD
Penicillamine—Decreased appetite—Erlotinib—pancreatic cancer	0.00093	0.00166	CcSEcCtD
Penicillamine—Alopecia—Gemcitabine—pancreatic cancer	0.000925	0.00165	CcSEcCtD
Penicillamine—Alopecia—Fluorouracil—pancreatic cancer	0.000909	0.00162	CcSEcCtD
Penicillamine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000907	0.00162	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—pancreatic cancer	0.000902	0.00161	CcSEcCtD
Penicillamine—Skin disorder—Sunitinib—pancreatic cancer	0.0009	0.00161	CcSEcCtD
Penicillamine—Anorexia—Sunitinib—pancreatic cancer	0.000883	0.00158	CcSEcCtD
Penicillamine—Pancytopenia—Docetaxel—pancreatic cancer	0.000881	0.00157	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000867	0.00155	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—pancreatic cancer	0.000867	0.00155	CcSEcCtD
Penicillamine—Anaemia—Irinotecan—pancreatic cancer	0.000864	0.00154	CcSEcCtD
Penicillamine—Urticaria—Tamoxifen—pancreatic cancer	0.000859	0.00153	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—pancreatic cancer	0.000849	0.00152	CcSEcCtD
Penicillamine—Body temperature increased—Erlotinib—pancreatic cancer	0.000846	0.00151	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000844	0.00151	CcSEcCtD
Penicillamine—Anaemia—Gemcitabine—pancreatic cancer	0.000842	0.0015	CcSEcCtD
Penicillamine—Leukopenia—Irinotecan—pancreatic cancer	0.000837	0.0015	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—pancreatic cancer	0.000836	0.00149	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—pancreatic cancer	0.000834	0.00149	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000832	0.00149	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000828	0.00148	CcSEcCtD
Penicillamine—Anaemia—Fluorouracil—pancreatic cancer	0.000828	0.00148	CcSEcCtD
Penicillamine—Leukopenia—Gemcitabine—pancreatic cancer	0.000815	0.00146	CcSEcCtD
Penicillamine—Renal failure—Docetaxel—pancreatic cancer	0.000813	0.00145	CcSEcCtD
Penicillamine—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000811	0.00145	CcSEcCtD
Penicillamine—Stomatitis—Docetaxel—pancreatic cancer	0.000806	0.00144	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—pancreatic cancer	0.000806	0.00144	CcSEcCtD
Penicillamine—Decreased appetite—Sunitinib—pancreatic cancer	0.000805	0.00144	CcSEcCtD
Penicillamine—Leukopenia—Fluorouracil—pancreatic cancer	0.000802	0.00143	CcSEcCtD
Penicillamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000797	0.00142	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000785	0.0014	CcSEcCtD
Penicillamine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000782	0.0014	CcSEcCtD
Penicillamine—Arthralgia—Gemcitabine—pancreatic cancer	0.000776	0.00139	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000774	0.00138	CcSEcCtD
Penicillamine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000772	0.00138	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.00077	0.00138	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00077	0.00138	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000767	0.00137	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000767	0.00137	CcSEcCtD
Penicillamine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000747	0.00133	CcSEcCtD
Penicillamine—Haemoglobin—Docetaxel—pancreatic cancer	0.000746	0.00133	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—pancreatic cancer	0.000745	0.00133	CcSEcCtD
Penicillamine—Haemorrhage—Docetaxel—pancreatic cancer	0.000743	0.00133	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000742	0.00133	CcSEcCtD
Penicillamine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00074	0.00132	CcSEcCtD
Penicillamine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000733	0.00131	CcSEcCtD
Penicillamine—Body temperature increased—Sunitinib—pancreatic cancer	0.000732	0.00131	CcSEcCtD
Penicillamine—Diarrhoea—Erlotinib—pancreatic cancer	0.000732	0.00131	CcSEcCtD
Penicillamine—Urethral disorder—Docetaxel—pancreatic cancer	0.000728	0.0013	CcSEcCtD
Penicillamine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000728	0.0013	CcSEcCtD
Penicillamine—Anorexia—Irinotecan—pancreatic cancer	0.000728	0.0013	CcSEcCtD
Penicillamine—Skin disorder—Gemcitabine—pancreatic cancer	0.000722	0.00129	CcSEcCtD
Penicillamine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000716	0.00128	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00071	0.00127	CcSEcCtD
Penicillamine—Anorexia—Gemcitabine—pancreatic cancer	0.000709	0.00127	CcSEcCtD
Penicillamine—Anorexia—Fluorouracil—pancreatic cancer	0.000697	0.00124	CcSEcCtD
Penicillamine—Vomiting—Tamoxifen—pancreatic cancer	0.000688	0.00123	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000686	0.00123	CcSEcCtD
Penicillamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000683	0.00122	CcSEcCtD
Penicillamine—Rash—Tamoxifen—pancreatic cancer	0.000682	0.00122	CcSEcCtD
Penicillamine—Dermatitis—Tamoxifen—pancreatic cancer	0.000681	0.00122	CcSEcCtD
Penicillamine—Vomiting—Erlotinib—pancreatic cancer	0.000681	0.00122	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000677	0.00121	CcSEcCtD
Penicillamine—Rash—Erlotinib—pancreatic cancer	0.000675	0.00121	CcSEcCtD
Penicillamine—Dermatitis—Erlotinib—pancreatic cancer	0.000674	0.0012	CcSEcCtD
Penicillamine—Angiopathy—Docetaxel—pancreatic cancer	0.000674	0.0012	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000666	0.00119	CcSEcCtD
Penicillamine—Decreased appetite—Irinotecan—pancreatic cancer	0.000663	0.00119	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000661	0.00118	CcSEcCtD
Penicillamine—Alopecia—Docetaxel—pancreatic cancer	0.000656	0.00117	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000652	0.00116	CcSEcCtD
Penicillamine—Mental disorder—Docetaxel—pancreatic cancer	0.000651	0.00116	CcSEcCtD
Penicillamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000646	0.00115	CcSEcCtD
Penicillamine—Nausea—Tamoxifen—pancreatic cancer	0.000643	0.00115	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—pancreatic cancer	0.000639	0.00114	CcSEcCtD
Penicillamine—Nausea—Erlotinib—pancreatic cancer	0.000636	0.00114	CcSEcCtD
Penicillamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000635	0.00113	CcSEcCtD
Penicillamine—Diarrhoea—Sunitinib—pancreatic cancer	0.000634	0.00113	CcSEcCtD
Penicillamine—Dysgeusia—Docetaxel—pancreatic cancer	0.000633	0.00113	CcSEcCtD
Penicillamine—Asthma—Epirubicin—pancreatic cancer	0.000626	0.00112	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—pancreatic cancer	0.00062	0.00111	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—pancreatic cancer	0.000614	0.0011	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000612	0.00109	CcSEcCtD
Penicillamine—Body temperature increased—Irinotecan—pancreatic cancer	0.000603	0.00108	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000603	0.00108	CcSEcCtD
Penicillamine—Anaemia—Docetaxel—pancreatic cancer	0.000598	0.00107	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—pancreatic cancer	0.000594	0.00106	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000591	0.00106	CcSEcCtD
Penicillamine—Vomiting—Sunitinib—pancreatic cancer	0.000589	0.00105	CcSEcCtD
Penicillamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000588	0.00105	CcSEcCtD
Penicillamine—Rash—Sunitinib—pancreatic cancer	0.000584	0.00104	CcSEcCtD
Penicillamine—Dermatitis—Sunitinib—pancreatic cancer	0.000584	0.00104	CcSEcCtD
Penicillamine—Urticaria—Fluorouracil—pancreatic cancer	0.000581	0.00104	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—pancreatic cancer	0.000579	0.00103	CcSEcCtD
Penicillamine—Leukopenia—Docetaxel—pancreatic cancer	0.000579	0.00103	CcSEcCtD
Penicillamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000578	0.00103	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000573	0.00102	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000568	0.00101	CcSEcCtD
Penicillamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000562	0.001	CcSEcCtD
Penicillamine—Arthralgia—Docetaxel—pancreatic cancer	0.00055	0.000983	CcSEcCtD
Penicillamine—Nausea—Sunitinib—pancreatic cancer	0.00055	0.000983	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—pancreatic cancer	0.00055	0.000982	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—pancreatic cancer	0.000548	0.00098	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000547	0.000977	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000547	0.000976	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—pancreatic cancer	0.000544	0.000971	CcSEcCtD
Penicillamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000539	0.000962	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—pancreatic cancer	0.000532	0.00095	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000528	0.000943	CcSEcCtD
Penicillamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000522	0.000933	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000521	0.00093	CcSEcCtD
Penicillamine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000517	0.000923	CcSEcCtD
Penicillamine—Skin disorder—Docetaxel—pancreatic cancer	0.000512	0.000915	CcSEcCtD
Penicillamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000509	0.000909	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—pancreatic cancer	0.000508	0.000906	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000506	0.000904	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—pancreatic cancer	0.000503	0.000899	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—pancreatic cancer	0.000503	0.000899	CcSEcCtD
Penicillamine—Anorexia—Docetaxel—pancreatic cancer	0.000503	0.000898	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—pancreatic cancer	0.000501	0.000895	CcSEcCtD
Penicillamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.0005	0.000893	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000495	0.000884	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—pancreatic cancer	0.000492	0.000879	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—pancreatic cancer	0.000491	0.000877	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000488	0.000872	CcSEcCtD
Penicillamine—Vomiting—Irinotecan—pancreatic cancer	0.000485	0.000867	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000482	0.000861	CcSEcCtD
Penicillamine—Rash—Irinotecan—pancreatic cancer	0.000481	0.00086	CcSEcCtD
Penicillamine—Dermatitis—Irinotecan—pancreatic cancer	0.000481	0.000859	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000481	0.000859	CcSEcCtD
Penicillamine—Vomiting—Gemcitabine—pancreatic cancer	0.000473	0.000844	CcSEcCtD
Penicillamine—Rash—Gemcitabine—pancreatic cancer	0.000469	0.000837	CcSEcCtD
Penicillamine—Dermatitis—Gemcitabine—pancreatic cancer	0.000468	0.000836	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—pancreatic cancer	0.000467	0.000834	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000466	0.000832	CcSEcCtD
Penicillamine—Vomiting—Fluorouracil—pancreatic cancer	0.000465	0.00083	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000463	0.000828	CcSEcCtD
Penicillamine—Rash—Fluorouracil—pancreatic cancer	0.000461	0.000823	CcSEcCtD
Penicillamine—Dermatitis—Fluorouracil—pancreatic cancer	0.00046	0.000822	CcSEcCtD
Penicillamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000459	0.000819	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000458	0.000817	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—pancreatic cancer	0.000454	0.000812	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000454	0.000811	CcSEcCtD
Penicillamine—Nausea—Irinotecan—pancreatic cancer	0.000453	0.00081	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—pancreatic cancer	0.000443	0.000791	CcSEcCtD
Penicillamine—Nausea—Gemcitabine—pancreatic cancer	0.000442	0.000789	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—pancreatic cancer	0.000439	0.000784	CcSEcCtD
Penicillamine—Nausea—Fluorouracil—pancreatic cancer	0.000434	0.000776	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—pancreatic cancer	0.000432	0.000772	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—pancreatic cancer	0.000427	0.000763	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—pancreatic cancer	0.00042	0.000751	CcSEcCtD
Penicillamine—Body temperature increased—Docetaxel—pancreatic cancer	0.000417	0.000745	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—pancreatic cancer	0.00041	0.000731	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—pancreatic cancer	0.000406	0.000725	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—pancreatic cancer	0.000403	0.00072	CcSEcCtD
Penicillamine—Agitation—Epirubicin—pancreatic cancer	0.000401	0.000716	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000395	0.000706	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—pancreatic cancer	0.00039	0.000697	CcSEcCtD
Penicillamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000389	0.000694	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—pancreatic cancer	0.000373	0.000666	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—pancreatic cancer	0.000371	0.000663	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—pancreatic cancer	0.000371	0.000662	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—pancreatic cancer	0.00037	0.000661	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000369	0.000658	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—pancreatic cancer	0.000361	0.000645	CcSEcCtD
Penicillamine—Diarrhoea—Docetaxel—pancreatic cancer	0.000361	0.000645	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000348	0.000622	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—pancreatic cancer	0.000346	0.000617	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—pancreatic cancer	0.000343	0.000613	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—pancreatic cancer	0.000342	0.000611	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000341	0.000609	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—pancreatic cancer	0.000339	0.000606	CcSEcCtD
Penicillamine—Vomiting—Docetaxel—pancreatic cancer	0.000335	0.000599	CcSEcCtD
Penicillamine—Rash—Docetaxel—pancreatic cancer	0.000333	0.000594	CcSEcCtD
Penicillamine—Dermatitis—Docetaxel—pancreatic cancer	0.000332	0.000594	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000324	0.000579	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000322	0.000576	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—pancreatic cancer	0.00032	0.000571	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—pancreatic cancer	0.000314	0.000561	CcSEcCtD
Penicillamine—Nausea—Docetaxel—pancreatic cancer	0.000313	0.00056	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—pancreatic cancer	0.000309	0.000553	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.0003	0.000536	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000286	0.000511	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—pancreatic cancer	0.000283	0.000505	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000281	0.000502	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000262	0.000468	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—pancreatic cancer	0.000262	0.000467	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00026	0.000465	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—pancreatic cancer	0.000243	0.000435	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000243	0.000433	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—pancreatic cancer	0.000226	0.000404	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000225	0.000402	CcSEcCtD
Penicillamine—Rash—Epirubicin—pancreatic cancer	0.000224	0.000401	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—pancreatic cancer	0.000224	0.0004	CcSEcCtD
Penicillamine—Nausea—Epirubicin—pancreatic cancer	0.000211	0.000378	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—pancreatic cancer	0.000209	0.000374	CcSEcCtD
Penicillamine—Rash—Doxorubicin—pancreatic cancer	0.000208	0.000371	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000207	0.00037	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—pancreatic cancer	0.000196	0.000349	CcSEcCtD
